BACTROBAN NASAL Rx
Generic Name and Formulations:
Mupirocin (as calcium) 2%; oint.
Indications for BACTROBAN NASAL:
Eradication of nasal colonization of methicillin-resistant S. aureus (MRSA) in adult patients and healthcare workers in certain institutional settings during outbreaks of infections with MRSA (see literature).
Apply approximately 0.25g to inside of each nostril twice daily for 5 days. Spread ointment by repeatedly closing and releasing the nostrils for 1 minute after application.
Avoid eyes. Nasal use in high-risk patients: see full labeling regarding autoinfection. Discontinue if sensitization or severe local irritation occurs. Prolonged use may result in superinfection. Pregnancy. Nursing mothers.
Nasal: avoid other concomitant nasal products.
Topical: burning, stinging, pain, itching. Nasal: headache, rhinitis, respiratory disorder, pharyngitis, taste perversion, burning/stinging, cough, pruritus; severe allergic reactions, C. difficile-associated diarrhea.
Oint—22g; Crm—15g, 30g; Nasal (single-use) (1g)—10
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age